Safeway jumps on $4 generic bandwagon

Just two years ago, Wal-Mart started its program to sell a select list of generic prescription drugs for just $4 as part of its entry into the healthcare and pharmaceutical spaces. It looks like the retail giant kicked off a major trend.

Now Safeway plans to follow suit and be the first full grocery retailer to hop on the $4 prescription bandwagon. Target also copied Wal-Mart's assertive sales strategy, and now consumers have access to literally hundreds of generic drugs at the $4 price point, including medications for thyroid disease and hypertension, as well as antibiotics. It's a trend that's sure to please price-conscious consumers, but give headaches to drugmakers already hurt generic competition.

- read the here's the Washington Post article
- get more on this story at MSNBC

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.